Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results

Egbelowo, Oluwaseun F.; Fox, Spencer J.; Gibson, Graham C.; Meyers, Lauren Ancel

doi:10.3201/eid3002.230200

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results

2 2024
By Egbelowo, Oluwaseun F. ; Fox, Spencer J. ; Gibson, Graham C. ; ...
http://dx.doi.org/10.3201/eid3002.230200
Source: Emerg Infect Dis. 2024; 30(2):388-391

[PDF-737.82 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Egbelowo, Oluwaseun F. ; Fox, Spencer J. ; Gibson, Graham C. ; Meyers, Lauren Ancel

Egbelowo, Oluwaseun F. ; Fox, Spencer J. ; Gibson, Graham C. ; Meyers, Lauren Ancel Less -
Description:

We devised a model to interpret discordant SARS-CoV-2 test results. We estimate that, during March 2020-May 2022, a patient in the United States who received a positive rapid antigen test result followed by a negative nucleic acid test result had only a 15.4% (95% CI 0.6%-56.7%) chance of being infected.
Subjects:

[+]

COVID-19 Testing COVID-19/diagnosis Diagnostic Tests, Routine Humans SARS-CoV-2 Sensitivity And Specificity
Keywords:

[+]

Coronavirus Coronavirus Disease COVID-19 Diagnostic Test PCR Rapid Antigen Test Respiratory Infections SARS Severe Acute Respiratory Syndrome Coronavirus 2 Viruses Zoonoses
Source:

Emerg Infect Dis. 2024; 30(2):388-391
Pubmed ID:

38217064
Pubmed Central ID:

PMC10826750
Document Type:

Journal Article
Funding:

R01 AI151176/AI/NIAID NIH HHSUnited States/ ; U01IP001136/ACL/ACL HHSUnited States/

R01 AI151176/AI/NIAID NIH HHSUnited States/ ; U01IP001136/ACL/ACL HHSUnited States/ Less -
Place as Subject:

United States
Volume:

30
Issue:

2
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:1455d2853f8ce5f21026723690c6fb2efeb9e0f0084ca5adc2752faf7923495f
Download URL:

https://stacks.cdc.gov/view/cdc/147342/cdc_147342_DS1.pdf
File Type:

	23-0200-F.gif	gif
	23-0200-F.jpg	jpeg
	23-0200-Techapp-s1.pdf	pdf
	23-0200.nxml	xml

More +